New Rapid-acting Antidepressants (Paperback, 1st ed. 2021)

This book discusses new candidates for rapid-acting antidepressants, such as (R)-ketamine, (2R,6R)-hydroxynorketamine, scopolamine, mGluR2/3 antagonists and AMPA receptor agonists. There are serious limitations to currently available antidepressants, such as delayed onset and low rates of efficacy. The discovery that a single dose of ketamine, an NMDAR antagonist, can produce rapid antidepressant effects that are sustained has led to new research in this area. In this volume, a variety of novel pharmaceutical treatments are examined. This volume would be useful to both researchers and clinicians who work in the field of pharmacology, specifically CNS drug treatments.

General

Imprint:	Springer Nature Switzerland AG
Country of origin:	Switzerland
Series:	Contemporary Clinical Neuroscience
Release date:	October 2022
First published:	2021
Editors:	Kenji Hashimoto • Mario Manto
Dimensions:	235 x 155mm (L x W)
Format:	Paperback
Pages:	149
Edition:	1st ed. 2021
ISBN-13:	978-3-03-079792-8
Categories:	Books > Medicine > Other branches of medicine > Psychiatry Books > Medicine > Other branches of medicine > Pharmacology > General Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
LSN:	3-03-079792-9
Barcode:	9783030797928

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!